GRK2: A Novel Cell-Specific Regulator of Severity and Duration of Inflammatory Pain
Authors:
- Niels EijkelkampNENiels Eijkelkamp
- Cobi J. HeijnenCHCobi J. Heijnen
- Hanneke L. D. M. WillemenHWHanneke L. D. M. Willemen
- Ronald DeumensRDRonald Deumens
- Elbert A. J. JoostenEJElbert A. J. Joosten
- Wendy KleibeukerWKWendy Kleibeuker
- Ilona J. M. Den HartogIHIlona J. M. Den Hartog
- Cindy T. J. van VelthovenCVCindy T. J. van Velthoven
- Cora NijboerCNCora Nijboer
- Mohammed A. NassarMNMohammed A. Nassar
- Gerald W. DornGDGerald W. Dorn
- John N. WoodJWJohn N. Wood
Open Access
- 10 February 2010
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 30 (6) , 2138-2149
Abstract
Chronic pain associated with inflammation is a common clinical problem, and the underlying mechanisms have only begun to be unraveled. GRK2 regulates cellular signaling by promoting G-protein-coupled receptor (GPCR) desensitization and direct interaction with downstream kinases including p38. The aim of this study was to determine the contribution of GRK2 to regulation of inflammatory pain and to unravel the underlying mechanism.GRK2+/−mice with an ∼50% reduction in GRK2 developed increased and markedly prolonged thermal hyperalgesia and mechanical allodynia after carrageenan-induced paw inflammation or after intraplantar injection of the GPCR-binding chemokine CCL3. The effect of reduced GRK2 in specific cells was investigated using Cre–Lox technology. Carrageenan- or CCL3-induced hyperalgesia was increased but not prolonged in mice with decreased GRK2 only in Nav1.8 nociceptors.In vitro, reduced neuronal GRK2 enhanced CCL3-induced TRPV1 sensitization.In vivo, CCL3-induced acute hyperalgesia inGRK2+/−mice was mediated via TRPV1. Reduced GRK2 in microglia/monocytes only was required and sufficient to transform acute carrageenan- or CCL3-induced hyperalgesia into chronic hyperalgesia. Chronic hyperalgesia inGRK2+/−mice was associated with ongoing microglial activation and increased phospho-p38 and tumor necrosis factor α (TNF-α) in the spinal cord. Inhibition of spinal cord microglial, p38, or TNF-α activity by intrathecal administration of specific inhibitors reversed ongoing hyperalgesia inGRK2+/−mice. Microglia/macrophage GRK2 expression was reduced in the lumbar ipsilateral spinal cord during neuropathic pain, underlining the pathophysiological relevance of microglial GRK2. Thus, we identified completely novel cell-specific roles of GRK2 in regulating acute and chronic inflammatory hyperalgesia.Keywords
This publication has 47 references indexed in Scilit:
- MAP kinase and painBrain Research Reviews, 2009
- Pathological and protective roles of glia in chronic painNature Reviews Neuroscience, 2009
- IL-1β signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2Brain, Behavior, and Immunity, 2008
- Physiological changes in GRK2 regulate CCL2‐induced signaling to ERK1/2 and Akt but not to MEK1/2 and calciumJournal of Neurochemistry, 2007
- Signaling Pathways in Sensitization: Toward a Nociceptor Cell BiologyNeuron, 2007
- TRPV1 expression‐dependent initiation and regulation of filopodiaJournal of Neurochemistry, 2007
- G protein-coupled receptor kinase 6 controls chronicity and severity of dextran sodium sulphate-induced colitis in miceGut, 2007
- The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signalingBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- A role for G protein‐coupled receptor kinase 2 in mechanical allodyniaEuropean Journal of Neuroscience, 2007
- p38 MAPK, Microglial Signaling, and Neuropathic PainMolecular Pain, 2007